![Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial | Annals of General Psychiatry | Full Text Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial | Annals of General Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12991-020-00319-x/MediaObjects/12991_2020_319_Fig1_HTML.png)
Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial | Annals of General Psychiatry | Full Text
![Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison | Semantic Scholar Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/587882ec415333b17ee82a97530445fcd0347d92/3-Table1-1.png)
Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison | Semantic Scholar
![Can U Take Topamax And Nuzak Together Topamax Cheap metabolic acidosis topamax symptoms topamax contre indication topiramate anxiety treatment topiramate. - ppt download Can U Take Topamax And Nuzak Together Topamax Cheap metabolic acidosis topamax symptoms topamax contre indication topiramate anxiety treatment topiramate. - ppt download](https://slideplayer.com/10411692/35/images/slide_1.jpg)
Can U Take Topamax And Nuzak Together Topamax Cheap metabolic acidosis topamax symptoms topamax contre indication topiramate anxiety treatment topiramate. - ppt download
![Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial - The Lancet Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011946/2003801181/gr1.gif)